Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Genome-based Drug Discovery

PUBLISHER: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | PRODUCT CODE: 2056824

Cover Image

PUBLISHER: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | PRODUCT CODE: 2056824

Nutrigenomics

PUBLISHED:
PAGES: 168 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5850
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Nutrigenomics Market to Reach US$1.4 Billion by 2032

The global market for Nutrigenomics estimated at US$479.0 Million in the year 2025, is expected to reach US$1.4 Billion by 2032, growing at a CAGR of 17.1% over the analysis period 2025-2032. Nutrigenomics Reagents & Kits, one of the segments analyzed in the report, is expected to record a 17.9% CAGR and reach US$982.4 Million by the end of the analysis period. Growth in the Nutrigenomics Services segment is estimated at 15.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$140.2 Million While China is Forecast to Grow at 16.3% CAGR

The Nutrigenomics market in the U.S. is estimated at US$140.2 Million in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$248.7 Million by the year 2032 trailing a CAGR of 16.3% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.0% and 14.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.7% CAGR.

Global Nutrigenomics Market - Key Trends and Drivers Summarized

How Is Nutrigenomics Reshaping Personalized Nutrition?

Nutrigenomics, the study of how genes interact with nutrients and dietary components, is redefining personalized nutrition by offering insights into how an individual’s genetic makeup influences their dietary needs and responses. This field of study helps identify genetic predispositions to various conditions like obesity, diabetes, and cardiovascular diseases, enabling the development of tailored nutritional plans that enhance health outcomes. Nutrigenomics is particularly beneficial in preventive healthcare, where dietary interventions based on genetic information can help manage or mitigate the risk of chronic diseases. With growing consumer awareness of health and wellness, nutrigenomics is becoming an essential component of personalized nutrition, offering more precise dietary recommendations for better health management.

What Are the Key Segments in the Nutrigenomics Market?

Key products include testing kits, services, and supplements designed for genetic-based nutrition interventions. In terms of application, nutrigenomics is used in dietary assessment, weight management, sports nutrition, and preventive healthcare, with preventive healthcare representing the largest segment due to the growing focus on disease prevention through personalized diets. The major end-users of nutrigenomics include research institutions, healthcare providers, genetic testing companies, and consumers seeking personalized diet plans. The increasing availability of direct-to-consumer (DTC) genetic testing services has expanded the reach of nutrigenomics, making it more accessible to a broader audience.

How Is Nutrigenomics Being Integrated Across Health and Wellness Sectors?

Healthcare providers are adopting nutrigenomics to deliver personalized dietary recommendations to patients, particularly for managing conditions like diabetes, obesity, and hypertension. Genetic testing companies offer nutrigenomic tests that provide consumers with insights into their genetic predispositions related to nutrient metabolism, food sensitivities, and vitamin deficiencies. The sports nutrition industry also utilizes nutrigenomics to optimize athletes’ diets based on genetic information, improving performance and recovery. Additionally, wellness programs and fitness centers are incorporating nutrigenomics as part of holistic health management, offering tailored dietary plans that align with individual genetic profiles. The integration of nutrigenomics into digital health platforms and mobile apps has further enhanced consumer access to personalized nutrition guidance.

What Factors Are Driving the Growth in the Nutrigenomics Market?

The growth in the Nutrigenomics market is driven by several factors, including increasing consumer awareness of the link between genetics, diet, and health outcomes. The rising demand for personalized nutrition solutions, driven by growing health consciousness and interest in preventive healthcare, has fueled the adoption of nutrigenomics. Advances in genetic testing technologies have made nutrigenomic analysis more accurate, affordable, and accessible, further boosting market growth. The increasing use of nutrigenomics in weight management, sports nutrition, and chronic disease prevention has also expanded its application. Additionally, the proliferation of DTC genetic testing services and the integration of genetic insights into digital health platforms have contributed to the broader adoption of nutrigenomics across healthcare and wellness sectors.

SCOPE OF STUDY:

The report analyzes the Nutrigenomics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Reagents & Kits, Services); Application (Obesity, Cancer Research, Cardiovascular Diseases, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

SELECT PLAYERS -

  • BASF SE
  • Cell-Logic
  • Danone S.A
  • Fagron Genomics S.L.U.
  • Genova Diagnostics
  • GX Sciences, LLC.
  • Koninklijke DSM N.V.
  • Metagenics, Inc.
  • Nutrigenomix
  • NutriProCan
  • Unilever
  • Xcode Life

WHAT SETS THIS REPORT APART FROM OTHERS?

Validated Sources - Human-curated validation and ranking of original source content, not AI LLM-generated synthetic content which dominates the internet today and has become a quick fix for most published research reports these days. Unlike most other published sources, our customers have access to full-stack source content. Our report draws from "real intelligence" balancing the power of AI against the risks of synthetically generated content and resulting biases. Customers have access to the source feeds.

Domain Expert Insights - Domain expert insights curated from enterprise, industry, academia, and government, consolidated from multilingual multimedia formats of text, voice, and images comprise a significant resource. Customers can request access to the pool of domain experts we track for this research project. We track 10,115 domain experts and their insights as part of this research project. Our customers may access our online tracker.

Annual subscription - Recommended for maximum value for your research dollar. Provides one additional full update during the 12 months and access to our research portal and interactive 10-user peer-to-peer collaboration drawing from our entire stack of validated project data which is updated on a weekly basis. Platform also enables adding enterprise data or third-party licensed content to build bespoke versions. Includes competitor tracking of up to 50 companies featured in the report.

Show more
Product Code: MCP22397

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Nutrigenomics - Global Key Competitors Percentage Market Share in 2026 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Personalized Nutrition and Health Supplements Spurs Growth in Nutrigenomics Market
    • Technological Advancements in Genomic Testing and Bioinformatics Strengthen Business Case for Adoption
    • Growing Focus on Tailored Diet Plans and Wellness Programs Expands Addressable Market
    • Expansion of Nutrigenomics in Clinical Laboratories, Nutrition Clinics, and Wellness Centers Fuels Market Growth
    • Increasing Adoption of Nutrigenomics in Weight Management, Metabolic Disorders, and Diabetes Care Expands Market Opportunities
    • Technological Innovations in DNA-Based Dietary Analysis and Nutrient Mapping Propel Market Expansion
    • Rising Focus on Preventive Healthcare and Reducing Chronic Disease Risks Drives Demand for Nutrigenomics
    • Growing Use of Nutrigenomics in Functional Foods, Sports Nutrition, and Dietary Supplements Expands Market Potential
    • Technological Advancements in AI-Powered Nutritional Recommendations and Microbiome Integration Propel Market Growth
    • Increasing Focus on Integrating Nutrigenomics with Telemedicine and Digital Health Platforms Drives Adoption
    • Rising Demand for Nutrigenomics in Fitness, Anti-Aging, and Mental Health Applications Strengthens Global Market
    • Expansion of Nutrigenomics in Personalized Meal Kits, Health Coaching, and Virtual Nutrition Counseling Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Nutrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 2: World Historic Review for Nutrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 3: World 13-Year Perspective for Nutrigenomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020, 2026 & 2032
    • TABLE 4: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 5: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 6: World 13-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
    • TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 9: World 13-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
    • TABLE 10: World Recent Past, Current & Future Analysis for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 11: World Historic Review for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 12: World 13-Year Perspective for Obesity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
    • TABLE 13: World Recent Past, Current & Future Analysis for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 14: World Historic Review for Cancer Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 15: World 13-Year Perspective for Cancer Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
    • TABLE 16: World Recent Past, Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 17: World Historic Review for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 18: World 13-Year Perspective for Cardiovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
    • TABLE 19: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 20: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 21: World 13-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
    • TABLE 22: World Nutrigenomics Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032

III. MARKET ANALYSIS

  • UNITED STATES
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 24: USA Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 25: USA 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 26: USA Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 27: USA Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 28: USA 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 30: Canada Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 31: Canada 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 33: Canada Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 34: Canada 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032
  • JAPAN
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 36: Japan Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 37: Japan 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 39: Japan Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 40: Japan 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032
  • CHINA
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 42: China Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 43: China 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 44: China Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 45: China Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 46: China 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032
  • EUROPE
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Nutrigenomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
    • TABLE 48: Europe Historic Review for Nutrigenomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 49: Europe 13-Year Perspective for Nutrigenomics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020, 2026 & 2032
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 51: Europe Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 52: Europe 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 54: Europe Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 55: Europe 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032
  • FRANCE
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 57: France Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 58: France 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 59: France Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 60: France Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 61: France 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032
  • GERMANY
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 63: Germany Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 64: Germany 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 66: Germany Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 67: Germany 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 69: Italy Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 70: Italy 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 72: Italy Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 73: Italy 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032
  • UNITED KINGDOM
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 75: UK Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 76: UK 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 77: UK Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 78: UK Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 79: UK 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 82: Rest of Europe 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 85: Rest of Europe 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032
  • ASIA-PACIFIC
    • Nutrigenomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 88: Asia-Pacific 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 91: Asia-Pacific 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Nutrigenomics by Product - Reagents & Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 93: Rest of World Historic Review for Nutrigenomics by Product - Reagents & Kits and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 94: Rest of World 13-Year Perspective for Nutrigenomics by Product - Percentage Breakdown of Value Sales for Reagents & Kits and Services for the Years 2020, 2026 & 2032
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
    • TABLE 96: Rest of World Historic Review for Nutrigenomics by Application - Obesity, Cancer Research, Cardiovascular Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
    • TABLE 97: Rest of World 13-Year Perspective for Nutrigenomics by Application - Percentage Breakdown of Value Sales for Obesity, Cancer Research, Cardiovascular Diseases and Other Applications for the Years 2020, 2026 & 2032

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!